The Lifetime Distribution of the Incremental Societal Costs of Autism
Top Cited Papers
Open Access
- 1 April 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 161 (4), 343-349
- https://doi.org/10.1001/archpedi.161.4.343
Abstract
Objective To describe the age-specific and lifetime incremental societal costs of autism in the United States. Design Estimates of use and costs of direct medical and nonmedical care were obtained from a literature review and database analysis. A human capital approach was used to estimate lost productivity. These costs were projected across the life span, and discounted incremental age-specific costs were computed. Setting United States. Participants Hypothetical incident autism cohort born in 2000 and diagnosed in 2003. Main Outcome Measures Discounted per capita incremental societal costs. Results The lifetime per capita incremental societal cost of autism is $3.2 million. Lost productivity and adult care are the largest components of costs. The distribution of costs over the life span varies by cost category. Conclusions Although autism is typically thought of as a disorder of childhood, its costs can be felt well into adulthood. The substantial costs resulting from adult care and lost productivity of both individuals with autism and their parents have important implications for those aging members of the baby boom generation approaching retirement, including large financial burdens affecting not only those families but also potentially society in general. These results may imply that physicians and other care professionals should consider recommending that parents of children with autism seek financial counseling to help plan for the transition into adulthood.Keywords
This publication has 20 references indexed in Scilit:
- Internet survey of treatments used by parents of children with autismResearch in Developmental Disabilities, 2006
- Visits to Complementary and Alternative Medicine Providers by Children and Adolescents in the United StatesAcademic Pediatrics, 2004
- Use of Complementary and Alternative Medicine Among Children Recently Diagnosed with Autistic Spectrum DisorderJournal of Developmental & Behavioral Pediatrics, 2003
- Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio.Journal of Autism and Developmental Disorders, 2003
- Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North CarolinaJournal of Child and Adolescent Psychopharmacology, 2002
- Higher-Functioning Pervasive Developmental Disorders: Rates and Patterns of Psychotropic Drug UseJournal of the American Academy of Child & Adolescent Psychiatry, 1999
- Controversial Therapies for Young Children with Developmental DisabilitiesInfants & Young Children, 1996
- Psychotropic and Anticonvulsant Drugs in Subjects with Autism: Prevalence and Patterns of UseJournal of the American Academy of Child & Adolescent Psychiatry, 1995
- Unconventional Medicine in the United States -- Prevalence, Costs, and Patterns of UseThe New England Journal of Medicine, 1993
- Microeconomics.Economica, 1982